Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Medtech 360 | Market Insights | Japan | 2021

The COVID-19 pandemic will negatively impact the Japanese GI endoscopy device market. Once the market stabilizes, however, it will expand modestly through 2029, due to the high incidence of gastric cancer and broad coverage for CRC screening in the country; that said, reimbursement cuts and demographic patterns will limit growth opportunities.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for GI endoscopy devices in Japan across a 10-year period.

Related Medtech Insights Reports

Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…